Dermatomyositis Clinical Trials Dermatomyositis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Baricitinib in Patients With Relapsing or na ïve Dermatomyositis
Condition:   Dermatomyositis Interventions:   Drug: Baricitinib;   Drug: Placebo Sponsor:   Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 22, 2021 Category: Research Source Type: clinical trials